Article
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy.
Cancer immunology, immunotherapy : CII - 2 Nov 2024
Ma Haochuan, Song Dili, Zhang Haibo, Li Taidong, Jin Xing
Abstract excerpt
BACKGROUND: Immune-related adverse events (irAEs) pose substantial challenges in the realm of cancer immunotherapy, frequently affecting treatment efficacy and patient safety. To address the urgent need for identifying risk factors associated with irAEs, we conducted a comprehensive phenotype-wide Mendelian randomization analysis (MR-PheWAS). METHODS: Utilizing publicly accessible genome-wide association study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
